Cargando…

Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development

The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Horawalavithana, Sameera, De Silva, Ravindu, Weerasekara, Nipuna, Kin Wai, N G, Nabeel, Mohamed, Abayaratna, Buddhini, Elvitigala, Charitha, Wijesekera, Primal, Iamnitchi, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703426/
https://www.ncbi.nlm.nih.gov/pubmed/36466588
http://dx.doi.org/10.1007/s10588-022-09370-3
_version_ 1784839845111136256
author Horawalavithana, Sameera
De Silva, Ravindu
Weerasekara, Nipuna
Kin Wai, N G
Nabeel, Mohamed
Abayaratna, Buddhini
Elvitigala, Charitha
Wijesekera, Primal
Iamnitchi, Adriana
author_facet Horawalavithana, Sameera
De Silva, Ravindu
Weerasekara, Nipuna
Kin Wai, N G
Nabeel, Mohamed
Abayaratna, Buddhini
Elvitigala, Charitha
Wijesekera, Primal
Iamnitchi, Adriana
author_sort Horawalavithana, Sameera
collection PubMed
description The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the AstraZeneca vaccine and their temporary interruption in September 2020. We analyzed URLs cited in Twitter messages before and after the temporary interruption of the vaccine development on September 9, 2020 to investigate the presence of low credibility and malicious information. We show that the halt of the AstraZeneca clinical trials prompted tweets that cast doubt, fear and vaccine opposition. We discovered a strong presence of URLs from low credibility or malicious websites, as classified by independent fact-checking organizations or identified by web hosting infrastructure features. Moreover, we identified what appears to be coordinated operations to artificially promote some of these URLs hosted on malicious websites.
format Online
Article
Text
id pubmed-9703426
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97034262022-11-28 Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development Horawalavithana, Sameera De Silva, Ravindu Weerasekara, Nipuna Kin Wai, N G Nabeel, Mohamed Abayaratna, Buddhini Elvitigala, Charitha Wijesekera, Primal Iamnitchi, Adriana Comput Math Organ Theory OriginalPaper The development of COVID-19 vaccines during the global pandemic that started in 2020 was marked by uncertainty and misinformation reflected also on social media. This paper provides a quantitative evaluation of the Uniform Resource Locators (URLs) shared on Twitter around the clinical trials of the AstraZeneca vaccine and their temporary interruption in September 2020. We analyzed URLs cited in Twitter messages before and after the temporary interruption of the vaccine development on September 9, 2020 to investigate the presence of low credibility and malicious information. We show that the halt of the AstraZeneca clinical trials prompted tweets that cast doubt, fear and vaccine opposition. We discovered a strong presence of URLs from low credibility or malicious websites, as classified by independent fact-checking organizations or identified by web hosting infrastructure features. Moreover, we identified what appears to be coordinated operations to artificially promote some of these URLs hosted on malicious websites. Springer US 2022-11-28 /pmc/articles/PMC9703426/ /pubmed/36466588 http://dx.doi.org/10.1007/s10588-022-09370-3 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle OriginalPaper
Horawalavithana, Sameera
De Silva, Ravindu
Weerasekara, Nipuna
Kin Wai, N G
Nabeel, Mohamed
Abayaratna, Buddhini
Elvitigala, Charitha
Wijesekera, Primal
Iamnitchi, Adriana
Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title_full Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title_fullStr Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title_full_unstemmed Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title_short Vaccination trials on hold: malicious and low credibility content on Twitter during the AstraZeneca COVID-19 vaccine development
title_sort vaccination trials on hold: malicious and low credibility content on twitter during the astrazeneca covid-19 vaccine development
topic OriginalPaper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703426/
https://www.ncbi.nlm.nih.gov/pubmed/36466588
http://dx.doi.org/10.1007/s10588-022-09370-3
work_keys_str_mv AT horawalavithanasameera vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT desilvaravindu vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT weerasekaranipuna vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT kinwaing vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT nabeelmohamed vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT abayaratnabuddhini vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT elvitigalacharitha vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT wijesekeraprimal vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment
AT iamnitchiadriana vaccinationtrialsonholdmaliciousandlowcredibilitycontentontwitterduringtheastrazenecacovid19vaccinedevelopment